2015 GI Cancers Symposium - Thursday
Read More
Christophe Mariette, MD,PhD, Department of Digestive and Oncologic Surgery, Claude Huriez University Hospital, presenting "Abstract 5: Hybrid minimally invasive versus open oesophagectomy for patients with oesophageal cancer: A multicenter, open-label, randomized phase III controlled trial, the MIRO trial.
San Francisco, CA - 2015 Gastrointestinal Cancers Symposium - San Francisco, CA: Christophe Mariette, MD,PhD, Department of Digestive and Oncologic Surgery, Claude Huriez University Hospital, presenting "Abstract 5: Hybrid minimally invasive versus open oesophagectomy for patients with oesophageal cancer: A multicenter, open-label, randomized phase III controlled trial, the MIRO trial. during Oral Abstract Session: Cancers of the Esophagus and Stomach at the Gastrointestinal Cancers Symposium 2015 here today, Thursday January 15, 2015. The Symposium is supported by ASCO, the American Society of Clinical Oncology, ASTRO, The American Society of Radiation Oncology, SSO, Society of Surgical Oncology and the AGA Institute. Over 3,000 physicians, researchers and allied healthcare professionals are attending the meeting which is being held at the Moscone West center in San Francisco and features the latest Gastrointestinal Cancers research in the areas of basic and clinical science. Date: Thursday January 15, 2015. Photo by © ASCO/Todd Buchanan 2015 Technical Questions: todd@medmeetingimages.com; Phone: 612-226-5154. GI15_DailyNews
